← All organizations

Fougera

For profitContributed to NME

Also known as: FOUGERA | Fougera Pharmaceuticals Inc. | FOUGERA PHARMS | FOUGERA PHARMS INC

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

First marketed drug

First NDA

Last known activity

Aug 1, 2016

Acquired by Novartis on Jan 1, 2012

Timeline

1840s

Jan 1, 1849
Fougera— Founded

1980s

Dec 14, 1982
alclometasone— NDA Organization

1990s

Dec 14, 1990
fluticasone— NDA Secondary Org

2000s

Aug 6, 2004
ciclopirox— Marketing Organization

2010s

Jan 1, 2012
Novartis— Acquired By

Drugs by trial phase (9 distinct, 15 trials)

Phase 4 (2 own, 0 via acquisition)

Phase 3 (5 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

roflumilast

Other trials (1 own, 0 via acquisition)

tea

Indications

Approved for

Studied for

Recent trials (25)

NCT02886715Study directorPhase 3Aug 1, 2016
NCT02886702Lead sponsorPhase 3Aug 1, 2016
NCT02886702Study directorPhase 3Aug 1, 2016
NCT02886715Lead sponsorPhase 3Aug 1, 2016
NCT02176538Study directorPhase 3Jun 1, 2012
NCT02176577Lead sponsorPhase 3Jun 1, 2012
NCT02176551Lead sponsorPhase 3Jun 1, 2012
NCT02176577Study directorPhase 3Jun 1, 2012
NCT02176551Study directorPhase 3Jun 1, 2012
NCT02176538Lead sponsorPhase 3Jun 1, 2012
NCT02147353CollaboratorN/ASep 1, 2011
NCT01232543Study directorPhase 2Nov 1, 2010
NCT01232543Lead sponsorPhase 2Nov 1, 2010
NCT00747032Study chairPhase 3Sep 1, 2010
NCT00747032Lead sponsorPhase 3Sep 1, 2010

Details

Founded: Melville, NY, US Jan 1, 1849
First NDA: Dec 14, 1982
Last known activity: Aug 1, 2016